查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301128

笔针市场规模,份额和趋势分析报告：按产品,按针长度,按治疗方法,按地区,细分市场趋势：2023-2030

Pen Needles Market Size, Share & Trends Analysis Report By Product (Standard & Safety Pen Needles), By Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), By Therapy (Insulin, Glucagon-like-Peptide-1), Region And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10个工作天内

价格

笔针市场增长和趋势

根据 GrandView Research, Inc. 的最新报告，预计到 2030 年，全球笔用针头市场规模将达到 77 亿美元，复合年增长率为 11.8%。

糖尿病患病率上升是笔针市场大幅增长的主要原因。 根据国家医学图书馆的数据，到 2023 年，糖尿病患者人数预计将增加 151 万人，这主要是由于人口老龄化。 全球糖尿病患病率如此之高，导致对笔用针头的需求增加。 糖尿病患者通常使用注射笔以便于给药。

此外，肥胖也是糖尿病的一个重要原因。 肥胖者通常患有 2 型糖尿病，这使他们成为目标市场收入最高的贡献者之一。 因此，2 型糖尿病患者是笔用针製造公司的常见目标人群。

技术进步的不断进步预计也将推动市场增长。 笔式针头可以提供舒适,简单的胰岛素输送方式。 这些设备技术先进，与註射器和小瓶相比，提供了一种更优越的替代药物输送方法。 例如，Becton,Dickinson 和 Company 发布了采用 Easy Flow 技术的 BD 超细纳米 4 毫米笔针。

笔针市场报告亮点

  • 由于与安全针头相比具有成本效益的针头，标准针头将在 2022 年占据市场主导地位
  • 由于技术的持续进步，预计安全笔针在预测期内将呈现良好的增长
  • 从针长来看，2022年8mm将占据最大份额。 这是因为这种针为糖尿病患者提供了便利。
  • 由于 4mm 针长较短，预计在预测期内将显示出有吸引力的复合年增长率
  • 由于糖尿病患者自我管理胰岛素的意识不断提高，胰岛素治疗将在 2022 年占据最大的市场份额
  • 欧洲将在 2022 年主导针笔市场，其次是北美，因为欧洲地区糖尿病患病率较高
  • 由于糖尿病患者对便捷给药的认识不断提高，预计亚太地区在预测期内将呈现最高的增长率

内容

第一章调查方法及范围

  • 市场细分和范围
  • 调查方法
  • 信息获取
  • 信息或数据分析
  • 市场形成和验证
  • 型号详细信息
  • 辅助信息列表
  • 主要信息列表
  • 目的

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 衝突快照

第 3 章笔针市场变量,趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/辅助市场前景
  • 采用和增长前景图
  • 行业价值链分析
    • 报销框架
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 笔针市场分析工具
    • 行业分析-波特分析
    • PESTEL 分析
    • 主要交易和战略联盟分析
    • 市场进入策略

第四章笔针市场：产品估算和趋势分析

  • 定义和范围
  • 2022 年和 2030 年产品市场份额
  • 细分仪表板
  • 按产品划分的全球笔针市场前景
  • 2018-2030 年以下市场规模,预测和趋势分析
    • 标准笔针
    • 安全笔针

第五章笔针市场：针长估算和趋势分析

  • 定义和范围
  • 2022 年和 2030 年针长市场份额
  • 细分仪表板
  • 按针长度划分的笔针市场前景
  • 2018-2030 年以下市场规模,预测和趋势分析
    • 4mm
    • 5mm
    • 6mm <里>8毫米
    • 10毫米 <里>12毫米

第六章笔针市场：治疗估算和趋势分析

  • 定义和范围
  • 2022 年和 2030 年治疗市场份额
  • 细分仪表板
  • 按治疗方式划分的笔针市场前景
  • 2018-2030 年以下市场规模,预测和趋势分析
    • 胰岛素
    • GLP-1
    • 生长激素

第七章笔针市场：区域估算和趋势分析

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2022 年区域市场份额和主要参与者
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2018-2030 年市场应用,预测和趋势分析：
  • 北美
    • 2018-2030 年市场预估和预测（收入）
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳大利亚
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 8 章竞争格局

  • 主要市场进入者的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商情况
    • 主要经销商和渠道合作伙伴名单
    • 主要客户
    • 2022 年主要参与者的市场份额分析
    • Novo Nordisk A/S
    • Becton
    • Dickinson and Company
    • TERUMO CORPORATION
    • Owen Mumford Ltd.
    • Ypsomed
    • B. Braun Melsungen AG
    • HTL-STREFA
    • UltiMed, Inc.
    • Allison Medical, Inc.
    • Artsana SPa
Product Code: GVR-1-68038-427-7

Pen Needles Market Growth & Trends

The global pen needles market size is expected to reach a value of USD 7.7 billion by 2030, expanding at a CAGR of 11.8%, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of the pen needles market. According to the National Library of Medicine, the number of people with diabetes is expected to climb by 1.51 million in 2023, owing primarily to the ageing population. Such high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which help in easy drug delivery.

In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors to the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles.

Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, Becton, Dickinson, and Company launched BD Ultra-Fine Nano 4mm Pen Needles with Easy Flow Technology, which will enable diabetic patients with easy adherence to insulin therapy regimens.

Pen Needles Market Report Highlights

  • Standard needles dominated the market in 2022 due to the availability of cost-effective needles as compared to safety needles
  • Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements
  • Amongst the needle lengths, 8mm held the largest share in 2022. This is due to the convenience offered by this needle type on diabetic patients
  • Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length
  • Insulin therapy accounted for the largest market share in 2022 due to rising awareness regarding self-administration of insulin amongst the diabetic patients
  • Europe dominated the pen needles market in 2022 followed by North America owing to the high prevalence of diabetes in the European region
  • Asia Pacific region is anticipated to exhibit the highest growth rate over the forecast period owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery
  • Some of the key players include Becton, Dickinson and Company, B. Braun Melsungen AG, Novo Nordisk A/S, Owen Mumford, Ltd., Ypsomed, HTL-STREFA, and TERUMO CORPORATION.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Needle Length
    • 1.1.3. Therapy
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Snapshot

Chapter 3. Pen Needles Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Growing prevalence of diabetes
      • 3.4.1.2. Technological advancements
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Preference for alternative drug delivery method
      • 3.4.2.2. Lack of skilled professionals
  • 3.5. Pen Needles Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Pen Needles Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Standard Pen Needles
    • 4.1.2. Safety Pen Needles
  • 4.2. Product Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Pen Needles Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Standard Pen Needles
      • 4.5.1.1. Standard pen needles market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Safety Pen Needles
      • 4.5.2.1. Safety pen needles market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Pen Needles Market: Needle Length Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. 4mm
    • 5.1.2. 5mm
    • 5.1.3. 6mm
    • 5.1.4. 8mm
    • 5.1.5. 10mm
    • 5.1.6. 12mm
  • 5.2. Needle Length Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Pen Needles Market by Needle Length Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. 4mm
      • 5.5.1.1. 4mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. 5mm
      • 5.5.2.1. 5mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. 6mm
      • 5.5.3.1. 6mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. 8mm
      • 5.5.4.1. 8mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.5. 10mm
      • 5.5.5.1. 10mm market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.6. 12mm
      • 5.5.6.1. 12mm market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Pen Needles Market: Therapy Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Insulin
    • 6.1.2. Glucagon-like-peptide-1
    • 6.1.3. Growth Harmone
  • 6.2. Therapy Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Pen Needles Market by Therapy Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Insulin
      • 6.5.1.1. Insulin market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Glucagon-like-peptide-1
      • 6.5.2.1. Glucagon-like-peptide-1 market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Growth Harmone
      • 6.5.3.1. Growth harmone market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Pen Needles Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2022 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2022
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 7.6.3. Canada
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 7.7. Europe
    • 7.7.1. UK
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive Scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 7.7.2. Germany
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 7.7.3. France
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 7.7.4. Italy
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 7.7.5. Spain
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 7.7.6. Denmark
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 7.7.7. Sweden
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 7.7.8. Norway
      • 7.7.8.1. Key country dynamics
      • 7.7.8.2. Competitive Scenario
      • 7.7.8.3. Regulatory framework
      • 7.7.8.4. Reimbursement scenario
      • 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 7.8. Asia Pacific
    • 7.8.1. Japan
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive Scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 7.8.2. India
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 7.8.3. China
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 7.8.4. South Korea
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 7.8.5. Australia
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 7.8.6. Thailand
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory framework
      • 7.8.6.4. Reimbursement scenario
      • 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 7.9. Latin America
    • 7.9.1. Brazil
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive Scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 7.9.2. Mexico
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 7.9.3. Argentina
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 7.10. MEA
    • 7.10.1. South Africa
      • 7.10.1.1. Key country dynamics
      • 7.10.1.2. Competitive Scenario
      • 7.10.1.3. Regulatory framework
      • 7.10.1.4. Reimbursement scenario
      • 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 7.10.2. Saudi Arabia
      • 7.10.2.1. Key country dynamics
      • 7.10.2.2. Competitive Scenario
      • 7.10.2.3. Regulatory framework
      • 7.10.2.4. Reimbursement scenario
      • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 7.10.3. UAE
      • 7.10.3.1. Key country dynamics
      • 7.10.3.2. Competitive Scenario
      • 7.10.3.3. Regulatory framework
      • 7.10.3.4. Reimbursement scenario
      • 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 7.10.4. Kuwait
      • 7.10.4.1. Key country dynamics
      • 7.10.4.2. Competitive Scenario
      • 7.10.4.3. Regulatory framework
      • 7.10.4.4. Reimbursement scenario
      • 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2022
    • 8.3.4. Novo Nordisk A/S
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Becton
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Dickinson and Company
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. TERUMO CORPORATION
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Owen Mumford Ltd.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Ypsomed
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. B. Braun Melsungen AG
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. HTL-STREFA
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. UltiMed, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Allison Medical, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Artsana S.P.a
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiative

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 5 North America Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 6 U.S. Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 8 U.S. Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 9 Canada Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 11 Canada Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 12 Europe Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 15 Europe Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 16 U.K. Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 17 U.K. Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 18 U.K. Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 19 Germany Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 21 Germany Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 22 France Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 23 France Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 24 France Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 25 Italy Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 27 Italy Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 28 Spain Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 30 Spain Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 31 Denmark Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 33 Denmark Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 34 Sweden Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 36 Sweden Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 37 Norway Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 39 Norway Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 44 Japan Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 46 Japan Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 47 China Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 48 China Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 49 China Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 50 India Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 51 India Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 52 India Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 53 Australia Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 55 Australia Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 56 Thailand Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 57 Thailand Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 58 Thailand Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 59 South Korea Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 61 South Korea Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 62 Latin America Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 64 Latin America Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 65 Latin America Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 66 Brazil Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 68 Brazil Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 69 Mexico Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 71 Mexico Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 72 Argentina Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 74 Argentina Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa Pen needles market, by region, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 79 South Africa Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 81 South Africa Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 85 UAE Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 87 UAE Pen needles market, by therapy, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Pen needles market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Pen needles market, by needle length, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Pen needles market, by therapy, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Pen needles market: market outlook
  • Fig. 14 Pen needles market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Pen needles market driver impact
  • Fig. 20 Pen needles market restraint impact
  • Fig. 21 Pen needles market strategic initiatives analysis
  • Fig. 22 Pen needles market: product movement analysis
  • Fig. 23 Pen needles market: product outlook and key takeaways
  • Fig. 24 Standard pen needles market estimates and forecast, 2018 - 2030
  • Fig. 25 Safety pen needles therapy market estimates and forecast, 2018 - 2030
  • Fig. 26 Pen needles market: needle length movement analysis
  • Fig. 27 Pen needles market: needle length outlook and key takeaways
  • Fig. 28 4mm market estimates and forecast, 2018 - 2030
  • Fig. 29 5mm market estimates and forecast, 2018 - 2030
  • Fig. 30 6mm market estimates and forecast, 2018 - 2030
  • Fig. 31 8mm market estimates and forecast, 2018 - 2030
  • Fig. 32 10mm market estimates and forecast, 2018 - 2030
  • Fig. 33 12mm market estimates and forecast, 2018 - 2030
  • Fig. 34 Pen needles market: therapy movement analysis
  • Fig. 35 Pen needles market: therapy outlook and key takeaways
  • Fig. 36 Insulin market estimates and forecast, 2018 - 2030
  • Fig. 37 Glucagon-like-peptide-1 market estimates and forecast, 2018 - 2030
  • Fig. 38 Glucagon-like-peptide-1 market estimates and forecast, 2018 - 2030
  • Fig. 39 Global Pen needles market: Regional movement analysis
  • Fig. 40 Global Pen needles market: Regional outlook and key takeaways
  • Fig. 41 Global market shares and leading players
  • Fig. 42 North America market share and leading players
  • Fig. 43 Europe market share and leading players
  • Fig. 44 Asia Pacific market share and leading players
  • Fig. 45 Latin America market share and leading players
  • Fig. 46 Middle East & Africa market share and leading players
  • Fig. 47 North America: SWOT
  • Fig. 48 Europe SWOT
  • Fig. 49 Asia Pacific SWOT
  • Fig. 50 Latin America SWOT
  • Fig. 51 MEA SWOT
  • Fig. 52 North America, by country
  • Fig. 53 North America
  • Fig. 54 North America market estimates and forecast, 2018 - 2030
  • Fig. 55 U.S.
  • Fig. 56 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 57 Canada
  • Fig. 58 Canada market estimates and forecast, 2018 - 2030
  • Fig. 59 Europe
  • Fig. 60 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 61 U.K.
  • Fig. 62 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 63 Germany
  • Fig. 64 Germany market estimates and forecast, 2018 - 2030
  • Fig. 65 France
  • Fig. 66 France market estimates and forecast, 2018 - 2030
  • Fig. 67 Italy
  • Fig. 68 Italy market estimates and forecast, 2018 - 2030
  • Fig. 69 Spain
  • Fig. 70 Spain market estimates and forecast, 2018 - 2030
  • Fig. 71 Denmark
  • Fig. 72 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 73 Sweden
  • Fig. 74 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 75 Norway
  • Fig. 76 Norway market estimates and forecast, 2018 - 2030
  • Fig. 77 Asia Pacific
  • Fig. 78 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 79 Japan
  • Fig. 80 Japan market estimates and forecast, 2018 - 2030
  • Fig. 81 China
  • Fig. 82 China market estimates and forecast, 2018 - 2030
  • Fig. 83 India
  • Fig. 84 India market estimates and forecast, 2018 - 2030
  • Fig. 85 Australia
  • Fig. 86 Australia market estimates and forecast, 2018 - 2030
  • Fig. 87 Thailand
  • Fig. 88 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 89 South Korea
  • Fig. 90 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 91 Latin America
  • Fig. 92 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 93 Brazil
  • Fig. 94 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 95 Mexico
  • Fig. 96 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 97 Argentina
  • Fig. 98 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 99 Middle East and Africa
  • Fig. 100 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 101 Saudi Arabia
  • Fig. 102 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 103 South Africa
  • Fig. 104 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 105 UAE
  • Fig. 106 UAE market estimates and forecast, 2018 - 2030
  • Fig. 107 Kuwait
  • Fig. 108 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 109 Participant categorization- Pen needles market
  • Fig. 110 Market share of key market players- Pen needles market